Earth Science Tech, Inc. reports news on its role as a diversified healthcare and wellness holding company with OTC-traded common stock. Recurring updates cover its compounding pharmacy operations, including RxCompoundStore.com and Mister Meds, and telemedicine platforms such as Peaks Curative, DOConsultation, MOCTeledoc and MyOnlineConsultation.com.
Company announcements also address financial results, public-company governance, auditor and investor-relations changes, industry-classification updates, FINRA quotation clearance, and portfolio activity outside healthcare through Avenvi real estate and asset management and MagneChef direct-to-consumer products.
Earth Science Tech (OTC: ETST) has announced its qualification and listing on the new OTCID tier of OTC Markets, a designation that recognizes companies meeting enhanced disclosure, transparency, and compliance standards. The Company, which operates as a strategic holding company focused on acquiring and optimizing high-potential businesses, views this achievement as a reflection of its commitment to corporate governance and investor communication.
CEO and Chairman Giorgio R. Saumat highlighted the company's turnaround over the past two years. The company expects this new designation to enhance investor confidence and support its growth initiatives.
Earth Science Tech (OTC: ETST) has reported exceptional financial results for the fiscal year ended March 31, 2025. The company achieved significant growth across all key metrics, with revenue reaching $33.1 million, representing a remarkable 177.05% increase year-over-year.
The company's performance showed substantial improvements in profitability, with net profit surging by 300.63% to $3.2 million. Cash position strengthened by 111.15% to $1.47 million, while total assets grew by 82.07% to $7.07 million. Additionally, ETST reduced its outstanding shares by 4.72%, demonstrating commitment to shareholder value.
Earth Science Tech, Inc. (OTC: ETST) has reported impressive financial results for the quarter ended June 30, 2024. The company, focused on the health and wellness industry, saw significant improvements across key financial metrics compared to the same period in 2023:
Revenue surged to $8,568,918, a 3,796.13% increase from $219,934 in the previous year. Gross profit rose to $6,410,434, up 4,208.99% from $148,769. The company achieved a net profit of $1,076,254, compared to a loss of $35,596 in 2023, marking a 3,123.53% improvement.
ETST's financial position also strengthened, with cash increasing by 1,404.97% to $1,384,407 and total assets growing by 62.04% to $4,772,247. These results demonstrate substantial growth and improved profitability for Earth Science Tech in the health and wellness sector.
Earth Science Tech, Inc. (OTC: ETST) announced its annual financial results for the fiscal year ending March 31, 2024, showcasing significant growth. The company reported $11.95 million in revenue, a remarkable 24,527.88% increase year-over-year (YOY), and a net profit of $812,139 compared to a loss of $365,405 the previous year, marking a 322.26% improvement. The total assets grew by 42.28% to $3.88 million, and cash reserves surged by 1,851.34% to $697,721. The gross profit also saw a substantial rise to $7.83 million, an increase of 35,387.28% YOY. Key operational highlights include the repurchase of 5,200,002 shares, the expansion of office and storage spaces, and enhancement of the Board of Directors with new members and the establishment of an audit committee. Additionally, the company expanded its workforce to 39 employees and 8 independent contractors. RxCompoundStore.com and Peaks Curative, , two of the company's subsidiaries, continue to expand their services and market presence in the health and wellness industry.
Earth Science Tech, Inc. (OTC: ETST) shares an annual letter from the CEO, highlighting significant accomplishments for the fiscal year ending March 31, 2024. The company has made substantial progress in various areas, such as expanding operations, hiring key personnel, repurchasing shares, and achieving impressive revenue growth. These achievements demonstrate management's dedication to shareholder value and strategic growth initiatives.
Summary not available.
Summary not available.
Summary not available.
Summary not available.